OncoScreen 001
Clinical Trial Title | Pilot Study of OncoScreen, a Novel In Vitro Pharmacophenotyping Assay for Breast and Ovarian Cancers |
Trial Status | Open to Enrollment |
Start Date | 01/26/2023 |
Location | hospitals |
Trial Type | Cancer - Adult Oncology |
Specific Condition | Breast and Ovarian Cancers |
Description | |
Eligibility Criteria | Screening for eligibility: study investigators will work with study coordinators to screen their own patients for potential inclusion in this study. Inclusion Criteria:
Exclusion Criteria:
Please contact Legacy Oncology Research for additional study inclusion/exclusion information. |
IRB Number | Central IRB |
Notes | |
Principal Investigator | Nathalie Johnson, MD |
Contact Name | Oncology Clinical Research |
Contact Phone | 503-413-8199 |
Contact Fax | 503-413-6920 |
Contact E-Mail | oncologyresearch@lhs.org |